Author: Asianet Pakistan

Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL

New Clinical Data, Patient Reported Outcomes, Real-World Utilization, and Comparative-Effectiveness Models to be Featured in Four Oral and One Poster Presentation PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the

Continue Reading...

Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL

New Clinical Data, Patient Reported Outcomes, Real-World Utilization, and Comparative-Effectiveness Models to be Featured in Four Oral and One Poster Presentation PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the

Continue Reading...

ChemOne’s Pengerang Energy Complex Project Awards EPCC Works to CNCEC

SINGAPORE, June 09, 2026 (GLOBE NEWSWIRE) — Pengerang Energy Complex Sdn. Bhd. (“PEC”) is pleased to announce the award of the Engineering, Procurement, Construction and Commissioning (“EPCC”) works for the Pengerang Energy Complex Project (“Project”) in Johor, Malaysia to China National Chemical Engineering Company Limited (“CNCEC”). The award marks a

Continue Reading...